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Background: Myxomatous mitral valve insufficiency is traditionally repaired by
posterior leaflet quadrangular resection and reconstruction. A simplified repair
technique without leaflet resection is described, and our initial experience is re-
viewed.
Methods: Thirty-nine consecutive patients with significant mitral regurgitation
underwent repair since January 2000 by placement of expanded polytetrafluoroeth-
ylene sutures between the leading (coapting) edge of the posterior leaflet and the
corresponding papillary muscle. An annuloplasty ring was placed, and no leaflet
tissue was resected. Patient medical records were obtained and retrospectively
reviewed.
Results: Twenty-five men and 14 women (median age, 61 years; range, 40-88 years)
had their mitral valve repaired by a variety of surgical approaches, including robotic
(18 patients), right thoracotomy (6 patients), and sternal (15 patients). Three patients
have required valve replacement: 1 at the initial operation, 1 because of dehiscence
of the annuloplasty ring, and 1 after subsequent rupture of a previously normal
native chorda. At follow-up (median, 12 months), 92% (33/36) of the remaining
patients had an intact mitral repair with no to mild regurgitation, 8.3% (3/36) of
patients had moderate regurgitation, and 92% of all patients (36/39) were in New
York Heart Association class I. There were no deaths.
Conclusions: Myxomatous mitral regurgitation due to posterior leaflet insufficiency
can be repaired without leaflet resection by placement of neochordae. This repair
technique is effective and is readily accomplished by traditional and minimally
invasive surgical approaches.
Myxomatous degeneration of the mitral valve is the most com-mon etiology of surgically significant mitral regurgitation foradults in the United States and other developed countries.1-4This type of valve failure is often due to prolapse or flail ofthe middle scallop of the posterior mitral leaflet.1,2 Mitralvalve repair has proven to be an effective, safe, and durable
means to treat this lesion.3-20 Repair is traditionally accomplished by quadrangular
resection of the prolapsed or flail posterior leaflet segment with reconstruction of the
leaflet and placement of an annuloplasty ring.5-8,15
Recent reports suggest that similar results can be obtained without removal of
leaflet tissue by using expanded polytetrafluoroethylene (ePTFE) suture neochordae
From the Departments of Cardiothoracic
Surgerya and Anesthesiology,b Keck
School of Medicine of the University of
Southern California, Los Angeles, Calif.
Read at the Twenty-ninth Annual Meeting
of The Western Thoracic Surgical Associ-
ation, Carlsbad, Calif, June 18-21, 2003.
Received for publication June 18, 2003;
revisions requested Aug 26, 2003; revisions
received Sept 9, 2003; accepted for publi-
cation Oct 7, 2003.
Address for reprints: John J. Nigro, MD,
Children’s Hospital Los Angeles, Depart-
ment of Cardiothoracic Surgery, 4650 Sun-
set Blvd, MS 66, Los Angeles, CA 90027
(E-mail: jnigro@chla.usc.edu).
J Thorac Cardiovasc Surg 2004;127:440-7
0022-5223/$30.00
Copyright © 2004 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2003.09.035
Surgery for Acquired Cardiovascular Disease Nigro et al
440 The Journal of Thoracic and Cardiovascular Surgery ● February 2004
A
CD
to resuspend the prolapsed or flail portion of the leaf-
let.4,21,22 This technique allows conservation of valve (leaf-
let) tissue and can be readily implemented via open, mini-
mally invasive, and robotic approaches. We have used this
technique to repair mitral regurgitation due to posterior
leaflet prolapse since January 2000 and believe that it is an
effective repair alternative to leaflet resection (quadrangu-
lar). A description of the technique and our experience with
this valve repair method are reviewed.
Materials and Methods
This study was approved by the University of Southern California
Institutional Review Board.
Patient Demographics
This is a review of our first 39 consecutive adult patients to
undergo repair for mitral valve regurgitation with neochordal
resuspension of the posterior mitral leaflet. It includes a retrospec-
tive review of each patient’s medical record. All procedures were
performed by a single surgeon (V.A.S.) between January 2000 and
May 2003. All patients had significant mitral regurgitation (mod-
erate to severe) due to prolapse of the posterior mitral leaflet.
Bileaflet prolapse was present in 3 patients.
Preoperative Assessment
Patients had a preoperative evaluation and a transthoracic echo-
cardiogram. A cardiac catheterization was performed in 38 patients
to define concomitant coronary artery pathology. Preoperative
New York Heart Association (NYHA) classification was deter-
mined on the basis of individual medical records.
Surgical Technique
Intraoperative transesophageal echocardiogram was performed on
each patient before the initiation of cardiopulmonary bypass. Peri-
operative transesophageal echocardiograms were performed dur-
ing hemodynamic stability and with normal volume and pressure
loading. Mitral valve repair was performed by median sternotomy,
a minimally invasive (right thoracotomy) approach, or a roboti-
cally assisted approach. All procedures were performed with hy-
pothermia (28°C-32°C) and cold blood cardioplegic hyperkalemic
cardiac arrest. The valve was directly inspected and tested, and the
mode of valve failure was determined. Posterior leaflet prolapse
was identified by the presence of ruptured or elongated chordae. A
single-armed 4-0 ePTFE suture was passed from the left atrium
through the prolapsed leaflet segment and back (through the
leaflet) to the atrial side. The suture entered leaflet tissue approx-
imately 0.5 cm from the free edge at the junction between the
rough and smooth portions of the leaflet, and it exited (the
Figure 1. Demonstration of placement of ePTFE neochordae, and the completed repair with an annuloplasty ring.
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leaflet atrial surface) near its free edge (Figure 1). The suture
was then brought through a secure area in the corresponding
papillary muscle and back through the leaflet (Figure 1). Once
tied, the knot was on the atrial side of the leaflet. Neochorda
length was adjusted on the basis of the length of adjacent
normal chordae to provide optimal leaflet coaptation. The valve
was tested, and additional sutures were placed as needed to
recreate valvular competence. A flexible annuloplasty ring
(Cosgrove-Edwards Annuloplasty System; Edwards Life-
sciences, Irvine, Calif) was sized on the basis of the anterior
leaflet and then secured with interrupted sutures. A postrepair
transesophageal echocardiogram was performed after separa-
tion from bypass. All patients received at least 6 weeks of
anticoagulation therapy with warfarin sodium (Coumadin).
Follow-up
All patients were contacted, underwent transthoracic echocardiog-
raphy, and were interviewed between March and June of 2003.
Follow-up was complete in all patients at a median of 12 months
(range, 0.5-38 months). An NYHA classification was determined
on the basis of the follow-up interview.
Echocardiogram
All preoperative and follow-up transthoracic echocardiograms
were completed via standard acoustic windows by using M-mode,
2-dimensional, and Doppler color flow modalities. Regurgitation
was graded by the amount of Doppler-measured turbulence in the
left atrium according to accepted criteria19 and was categorized as
zero to mild, moderate, and severe.
Statistical Analysis




There were 25 men and 14 women, with a median age of 61
years (range, 40-88 years). Fifteen percent of the patients
(6/39) were asymptomatic with known mitral valve prolapse
and significant mitral regurgitation on echocardiogram. The
most common symptom was shortness of breath, which was
present in 26 (67%) of 39 patients. One patient presented
with angina due to significant coronary artery disease. Pre-
operative NYHA classification for the patients is presented
in Figure 2. Surgically significant coronary artery disease
was present in 10% of the patients (4/39). One patient had
prior coronary revascularization. Preoperative echocardio-
gram demonstrated severe (4) mitral regurgitation in 67%
(26/39) and moderate (3) mitral regurgitation in the rest
(33%; 13/39; Figure 3).
Procedure
Forty-six percent of the patients (18/39) had their mitral
valve repair completed robotically, 39% (15/39) had repair
via a median sternotomy, and the remaining 15% (6/39) had
a minimally invasive (right thoracotomy) surgical approach
(Figure 4). Two patients were converted from a robotic-
assisted to an open or right thoracotomy approach. At op-
eration, all patients had prolapse of the posterior mitral
leaflet, and 3 had both leaflets involved. Complete flail due
to ruptured chordae was present in 21 (54%) patients. The
middle scallop of the posterior leaflet was the only (leaflet)
segment to be prolapsed in 26 (67%) patients. Concomitant
procedures were performed in 21% (8/39) of the patients
and included coronary revascularization (n  4), modified
Figure 2. New York Heart Association classification for patients before surgery and at follow-up.
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maze (n  3), and aortic valve replacement (n  1).
Perfusion and cross-clamp times for the entire group and by
surgical approach are listed in Table 1. Each ePTFE suture
placed formed 2 neochordae (Figure 1). Annuloplasty ring
size, number of sutures, and number of neochordae are
listed in Table 2.
Mortality and Morbidity
There were no operative deaths, and all patients are alive at
follow-up (June 2003). Re-exploration for bleeding was
performed in 4 patients. Postoperative atrial fibrillation or
supraventricular tachycardia occurred in 10 patients. Pace-
makers were placed in 3 patients, and an automatic implant-
Figure 3. The surgical approach used to complete mitral valve repair.
Figure 4. Presentation of echocardiographic grading of mitral regurgitation for patients before surgery and at
follow-up. The 3 patients with mitral valve replacement are not included in the follow-up group.
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able cardioverter defibrillator was placed in 1. The median
intensive care unit stay was 2 days (range, 2-12 days), and
the median hospital stay was 6 days (range, 2-14 days).
There were no documented thromboembolic events.
Reoperation
In 1 patient, mitral valve repair was unsuccessful, the repair
was abandoned, and the valve was replaced at the initial
operation. He has done well and was in NYHA class I at
follow-up. Two of the remaining 38 patients have under-
gone reoperation. In 1 of these 2 patients, the annuloplasty
ring dehisced, resulting in severe mitral incompetence and
recurrence of symptoms 4 months after valvuloplasty. This
patient had subsequent mitral valve replacement and was in
functional class I at follow-up. The second patient experi-
enced recurrence of symptoms and severe mitral regurgita-
tion 3 months after valvuloplasty. An intact neochordal
repair was found at reoperation, but there was native chordal
rupture and flail at an adjacent valve segment that had been
normal at the primary operation. This patient also under-
went mitral valve replacement and was in functional class I
at follow-up.
Follow-up Echocardiograms
The degree of mitral regurgitation at echocardiographic
follow-up is shown in Figure 3. Three patients who under-
went valve replacement are not included in the follow-up
portion of Figure 3. Of the remaining 36 patients, 33 (92%)
had mild or less regurgitation, and 3 (8%) had moderate
regurgitation. One of these 3 patients is asymptomatic and
in NYHA functional class I, and 1 is in class II. The third
patient had significant coronary disease. He did well after
his combined mitral valve repair and coronary revascular-
ization and was in functional class I with trace mitral
regurgitation at 20 months after surgery. Subsequently, he
experienced aspiration pneumonitis and sepsis after a lobec-
tomy for lung cancer and now has moderate mitral regur-
gitation. All 36 patients had a morphologically intact valve
repair on 2-dimensional echocardiogram, with echocardio-
graphic regurgitation (when present) due to small eccentric
jets on Doppler analysis.
Functional Status
NYHA functional classification for all patients before sur-
gery and at follow-up is presented in Figure 2. The 1 patient
in functional class IV is now debilitated after lobectomy
complicated by aspiration and sepsis. The patient in func-
tional class III had severe coronary artery disease; she had
a competent mitral valve without regurgitation on echocar-
diogram but had significant left ventricular dysfunction. The
patient in functional class II had moderate mitral regurgita-
tion on echocardiogram, had normal ventricular function,
and improved relative to preoperative status.
Discussion
Myxomatous degeneration of the mitral valve is a common
etiology for surgically significant mitral regurgitation. Pro-
lapse or flail of the posterior middle scallop is the most
common cause of valvular incompetence.1-4 Repair for pos-
terior leaflet failure traditionally consists of quadrangular
resection, annuloplasty ring placement, and possible sliding
annuloplasty.3-8,10,13,15,18,20 This classic approach to valve
repair can be complex and requires the removal of valve
tissue. Recent reports have suggested that similar results can
be obtained without resection and sacrifice of potentially
valuable leaflet tissue.4,21,22 Placement of anterior leaflet
neochordae is an accepted method of recreating valve com-
petence for anterior leaflet prolapse,4,12,14 and neochordae
have been used to repair bileaflet and posterior leaflet pro-
lapse.4,12,14,21,22 Investigators have reported excellent long-
term durability for repairs with ePTFE neochordae.19,23
However, no prior study has focused on the repair of pos-
terior leaflet prolapse (or flail) by placement of neochordae
and without leaflet resection.
We believe that neochordal repair for posterior leaflet
prolapse offers several advantages over traditional repair
techniques. It requires relatively few steps and is expedi-
tiously completed. These attributes are especially advanta-
geous when applied to valve repair with a minimally inva-
sive or robotic approach. Chordal preservation is an
TABLE 1. Perfusion and crossclamp times
Variable
All patients (n  39) Robotic (n  18) Minimally invasive (n  15) Transsternal (n  6)
Perfusion Crossclamp Perfusion Crossclamp Perfusion Crossclamp Perfusion Crossclamp
Mean  SD (min) 100  39 71  30 130  25 93  19 92  46 61  43 67  15 48  14
Median (min) 99 66 123 87 89 52 64 50
Range (min) 39-183 24-142 83-183 63-138 39-170 24-142 45-79 28-79
TABLE 2. Operative data
Variable No. sutures Neochordae
Annuloplasty
ring size
Median 2 4 30
Mode 1 2 30
Range 1-4 2-8 26-34
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important goal for mitral operation because it provides for
coordinated and optimal function of the left ventricle and
the mitral mechanism.11,24-28 We believe that chordal re-
construction of the posterior leaflet restores anatomic and
dynamic relationships, which may be jeopardized by resec-
tion of leaflet tissue, and that reconstruction without resec-
tion allows for a physiologic distribution of forces and stress
on valve components and the left ventricle. These combined
effects could minimize negative effects on cardiac function
after valvuloplasty and maximally preserve all potential
contributions to cardiac function.
Neochordal repair of the posterior leaflet is a versatile
technique, which was readily and successfully applied via
open, minimally invasive, and robotic approaches. Median
crossclamp and perfusion times are consistently shorter
(Table 1) than those reported by Chitwood and associates29
for robotic mitral repair (crossclamp, 126 minutes; perfu-
sion, 168 minutes) and by Mohty and colleagues3 for open
valvuloplasty (perfusion, 86 minutes).
Most series of mitral valve repairs have low operative
(2%) and long-term mortality rates.3-8,10,13,15,18,20 Periop-
erative and late deaths are usually due to cardiac fail-
ure.4,5,13,18 Myocardial failure was responsible for 3 peri-
operative deaths reported in the series by Gillinov and
associates18; in 2 of these, a return to bypass was required to
fix residual regurgitation, implicating the detrimental effects
of prolonged clamp and myocardial ischemic times. In our
initial experience with neochordal repair, there have been no
perioperative deaths, no prolonged intensive care unit stays,
and no mortalities. The potential advantages of neochordal
repair include simplicity and maximal conservation of valve
tissue, which limit both bypass time and ventricular dys-
function. These factors may have salutary effects on cardiac
function, perioperative mortality, and long-term survival
after mitral valve repair.
Rates for reoperation and death have been the focal point
for many reports of follow-up after mitral valvuloplas-
ty,3,5,18 but postoperative functional status has not been
consistently described. In a review of their experience with
mitral valve repair for myxomatous disease, David and
colleagues13 reported that most patients were in NYHA
functional class I, and in a subsequent report, the classifi-
cation was 66% in class I, 26% in class II, and 7% in class
IV.4 Xu and associates30 reported that 96% of patients were
in class I or II after mitral valve repair. Predictors for
postoperative cardiac function (congestive heart failure) af-
ter surgical correction of mitral regurgitation were preoper-
ative ejection fraction, the presence of coronary artery dis-
ease, and preoperative NYHA classification.17 Few of these
preoperative risk factors were present in our patient popu-
lation, and at follow-up, 92% (33/36) of neochordal repair
patients were in functional class I, and 94% (34/36) were in
class I or II. All patients who had valve replacement were in
functional class I. The 2 patients in functional class III and
IV at follow-up both had multivessel coronary artery dis-
ease. One patient had a reduced ejection fraction and had
coronary artery bypass operation before her combined redo
revascularization and valve repair. This patient has signifi-
cant left ventricular dysfunction, has no mitral regurgitation,
and is in NYHA class III. The patient in class IV has normal
left ventricular function but is debilitated after complica-
tions after lobectomy for lung cancer. Before this, he was in
functional class I at 20 months of follow-up.
Few reports have presented complete echocardiographic
follow-up for patients after mitral valve repair.3-5,13,18 Re-
view of available reports indicates that mitral regurgitation
is present on Doppler echocardiogram in a significant por-
tion of patients after mitral valvuloplasty, with moderate or
greater regurgitation in 8% to 29% of patients and trace to
mild regurgitation in 19% to 67%.5,19,20,30 In our series,
follow-up 2-dimensional mode echocardiography demon-
strated an intact repair with good leaflet apposition and no
prolapse for 35 of the 36 patients (who did not have valve
replacement). In these patients, Doppler analysis revealed
no to mild regurgitation in 33 patients and moderate regur-
gitation in 3. When present, mitral regurgitation was almost
always due to small eccentric jets (2-5 mm wide), and these
are of unknown clinical significance. In 1 patient, 2-dimen-
sional echocardiogram demonstrated a morphologically in-
tact repair with mild prolapse of the anterior leaflet and
moderate regurgitation on Doppler analysis.
Freedom from reoperation after mitral repair is 85% to
95%.3-20 Longer follow-up is associated with an increased
need for reoperation.3 In the series reported by Gillinov and
associates,18 40% to 50% of reoperations occurred within 1
year of valve repair, and the remainder occurred over long-
term follow-up. In a review of reoperation for failed valvu-
loplasty, the median time between operations was 2.4 years
and ranged from 2 months to 25.3 years.9 In our series,
mitral valve repair was abandoned in 1 patient because of
irreparable anatomy. Two patients (5%) who initially had
successful repairs required reoperation within 6 months of
the original operation. In 1 patient of the 2, the annuloplasty
ring dehisced, and the other had a newly ruptured native
chorda. Both of these mechanisms of valvuloplasty failure
have been reported and are accepted (and significant) etiol-
ogies for early recurrence of regurgitation after valve re-
pair.9 Early results for reoperation in our series compare
favorably to results for more technically complex repairs.
In conclusion, myxomatous mitral regurgitation due to
posterior leaflet prolapse can be repaired by placement of
neochordae and an annuloplasty ring. This repair method
avoids leaflet resection, allows maximal conservation of
valve tissue, and is readily accomplished by traditional and
minimally invasive approaches.
Nigro et al Surgery for Acquired Cardiovascular Disease
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Discussion
Dr Gabriel Aldea (Seattle, Wash). In the past 15 years,
techniques for neochordal replacement with ePTFE were intro-
duced by Drs Frater, David, Schaff, and others. These techniques
significantly increased the likelihood of repair for myxomatous
mitral valve pathology and were demonstrated to have excellent
long-term (10-year) durability, which is superior to chordal short-
ening and transfer. Expanded PTFE chordal replacement had been
applied primarily to anterior or mixed anterior posterior leaflet
prolapse, but even in Dr David’s series from 1997, 15% of all
patients with isolated posterior leaflet prolapse were treated this
way. Dr David’s criteria for using chordal replacement with
ePTFE over the traditional quadrangular resection or reconstruc-
tion with ring annuloplasty were quite specific and included ex-
tensive resection of P2 (which included a resection of more than a
third of the posterior leaflet or 1.5 cm), multiple elongated P2
chords, or paracommissural posterior leaflet pathology. He specif-
ically cautioned that extensive P2 resection needed to be accom-
panied by a Carpentier ring annuloplasty to prevent both systolic
anterior motion and posterior wall motion abnormality. The Uni-
versity of Southern California team under Dr Vaughn Starnes’
leadership has logically expanded the concept of neochordal repair
to leaflet preservation routinely to patients with isolated posterior
chord prolapse. They reported an initial experience with 39 pa-
tients with complete but relatively short follow-up, with a median
follow-up of 1 year. Their results are excellent, with 0% mortality,
excellent relief of symptoms, and echocardiographic confirmation
of minimal to no mitral regurgitation in 92% of the patients,
confirming that this approach in fact is both effective and success-
ful. Three patients, however, required mitral valve replacement, as
we have seen: 1 in the operating room and 2 within 4 months of
surgery, 1 again for an annuloplasty ring dehiscence, and another
for a new ruptured adjacent native chord pathology.
I have several questions for the authors. Do these 39 consecu-
tive patients treated over a 20-year period of time represent the
entire mitral valve repair population for posterior or mixed poste-
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rior anterior pathology, or is this a selected subset of patients, and,
if so, how were these patients selected?
Dr Nigro. We have made a commitment to attempt repair of
the posterior leaflet prolapse patients in this manner and this
represents the bulk of those patients. Since January of 2000 the
senior author has adopted neochordal reconstruction as his pre-
ferred valvuloplasty technique for posterior leaflet prolapse or flail
due to myxomatous degeneration. During the study period he
performed no repairs using leaflet resection for this valve pathol-
ogy. Other surgeons at this institution may have continued to use
traditional valvuloplasty methods; however the majority of pa-
tients with myxomatous posterior leaflet prolapse (at this center)
underwent valve repair by the senior author with the neochordal
technique. This series represents the bulk of patients with (repair-
able) regurgitation due to myxomatous degeneration and prolapse
or flail of the posterior mitral leaflet that underwent valvuloplasty
at this center during the study period.
Patient selection was as stated in the paper: 39 consecutive
adult patients with significant (severe) mitral regurgitation due to
myxomatous mitral degeneration and prolapse or flail of the pos-
terior mitral leaflet, and who met the traditional criterion for mitral
valvuloplasty.
Our center completes roughly 100 to 200 adult mitral valve
operations per year. Due to our patient demographics, an unusually
large percentage (relative to most of North America) has rheu-
matic, congenital, or infective etiologies of mitral disease. Neo-
chordal reconstruction for isolated anterior leaflet prolapse is an
accepted and proven repair method; patients with this pathology
have been excluded to provide for a focused review of posterior
leaflet repair. Because of these factors and our desire to focus (this
study) on adult patients undergoing initial repair for myxomatous
posterior leaflet disease, the study group consists of 39 consecutive
patients acquired in roughly 2 to 3 years.
Dr Aldea. Most of us are reasonably satisfied with the French
correction, that is, the quadrangular resection reconstruction with
ring annuloplasty, and are aware that 10% of patients treated that
way will present with reoperation and typically with a flail because
of a new rupture of an adjacent chord, and typically 50% of those
failures occur early. Was your motivation for moving to this repair
caused by dissatisfaction with long-term outcomes or by the newer
restrictions introduced by minimally invasive approaches?
Dr Nigro. The answer to that question is that it was influenced
by both issues. Decades of research and clinical work have con-
sistently indicated that maximal conservation of valvular and sub-
valvular apparatus is critical for optimal valve and ventricular
function and to minimize valvuloplasty morbidity and mortality.
We were clearly motivated by the combined desires to develop a
valvuloplasty technique that provides for valvular competence,
optimizes cardiac/ventricular function, limits bypass time, and
facilitates minimally invasive techniques.
Dr Aldea. My next question is a somewhat technical one.
Although Dr Starnes makes it look easy, how difficult is it to assess
the proper height of repair for these neochords, and when you
preserve the entire posterior leaflet, do you make any adjustment
for the size of the annuloplasty ring that is implanted? From your
manuscript, the mean size of the annuloplasty ring is 30, so I
assume that there is no correction or no change in the way you
normally or previously sized the annuloplasty ring.
Dr Nigro. Adjustment of chordal length is critical for the
successful application of this valvuloplasty technique; it is accom-
plished based on the adjacent normal chordae and to provide for
optimal leaflet coaption at or below the level of the annulus. It is
an acquired skill that requires significant knowledge of and expe-
rience with mitral valvuloplasty techniques.
A flexible partial ring was utilized and sized based on the
anterior leaflet as has been widely advocated for mitral valvulo-
plasty. We believe that the neochordal repair technique minimizes
the risk of SAM because valvular restructuring is avoided and a
flexible annuloplasty ring is used.
Dr Aldea. The reason why I asked the question is that we know
from finite element analysis, for example, from Dr Kunstleman’s
work, that although you can achieve competence with chords being
just the right length or slightly longer, tension on adjacent chords
may vary quite a bit, and perhaps that is the explanation for one of
the delayed chordal ruptures that was seen.
Finally, do the authors believe that the early failure rate of 5%
will be significantly reduced with increasing experience or with
more specific indications for this?
Dr Nigro. You know it is possible that the failure rate will be
reduced with more experience; but the failures may prove to be
independent of repair type. The first patient, who underwent re-
placement intraoperatively, represents an attempt to repair a very
dysmorphic valve. And it was unsuccessful. I think these things
happen in most series and maybe are not included in the results.
The other 2 patients are interesting because they represent failures
within the first year due to widely known failure mechanisms.
Annuloplasty ring dehiscence was present in roughly half of the
early failures in the Mayo series clinic review of open valvulo-
plasty failures, and chordal rupture was apparent in that group as
well in roughly the same percentage. Now only time will tell. It’s
not surprising that repairs break down early just like they have in
other series and hopefully in a follow-up study we will be able to
tell you what happens over the long term. Roughly 50% of failures
happened in the first year in both the Cleveland Clinic series and
the Mayo series and the remaining happened over time, so time
will tell.
Dr Aldea. And finally, in the evolution of the American repair
from our French roots, do you see any circumstances in which a
ring annuloplasty would not be necessary?
Dr Nigro. You know the literature suggests most experienced
valve surgeons are committed to a ring annuloplasty. I believe
anything is possible but I think at this point a ring annuloplasty is
an integral part of repair. You bring up an interesting point. I think
that the Texas group has recently published a series called “The
American Correction” in which they have performed most of their
recent valve repairs without leaflet resection, so this is a very
interesting topic.
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